Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report

BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Res Notes
Autores principales: Koie, Takuya, Ohyama, Chikara, Okamoto, Akiko, Yamamoto, Hayato, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/
https://ncbi.nlm.nih.gov/pubmed/24267160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares